Nicolas Ebel
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Oncology 4
- Cancer-related Molecular Pathways 2
-
- Glycosylation and Glycoproteins Research 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- S. Sigrist (2 shared papers)M. Pinget (2 shared papers)Eric Marchioni (1 shared paper)Fabienne Baffert (2 shared papers)Rita Andraos (2 shared papers)Nathalie Reix (1 shared paper)Remmelt Van der Werf (1 shared paper)N. Jeandidier (1 shared paper)
- Journals
- Cancer Research (2 papers)International Journal of Pharmaceutics (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)Journal of Pharmacokinetics and Pharmacodynamics (1 paper)
- Partner nations
- SwitzerlandChinaUnited States
In The Last Decade
Nicolas Ebel
7 papers receiving 214 citations
Peers
Comparison fields: 5 of 57
- Pharmaceutical Science 53
- Genetics 69
- Hematology 44
- Biomaterials 24
- Molecular Biology 106
Countries citing papers authored by Nicolas Ebel
This map shows the geographic impact of Nicolas Ebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Ebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Ebel more than expected).
Fields of papers citing papers by Nicolas Ebel
This network shows the impact of papers produced by Nicolas Ebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Ebel. The network helps show where Nicolas Ebel may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Ebel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 79 | |
| 2 | 2013 | 60 | |
| 3 | 2016 | 26 | |
| 4 | 2011 | 22 | |
| 5 | 2005 | 14 | |
| 6 | 2018 | 10 | |
| 7 | 2024 | 6 |
About Nicolas Ebel
Nicolas Ebel is a scholar working on Oncology, Molecular Biology, Genetics, Surgery and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 217 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Glycosylation and Glycoproteins Research (1 paper), Diabetes and associated disorders (1 paper), Adenosine and Purinergic Signaling (1 paper), Polysaccharides and Plant Cell Walls (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Pharmaceutical Science (53 citations), Genetics (69 citations), Hematology (44 citations), Biomaterials (24 citations) and Molecular Biology (106 citations). Nicolas Ebel has collaborated with scholars based in Switzerland, China and United States. Frequent co-authors include S. Sigrist, M. Pinget, Eric Marchioni, Fabienne Baffert, Rita Andraos, Nathalie Reix, Remmelt Van der Werf, N. Jeandidier, E. Seyfritz and Yves Frère. Their work appears in journals such as Cancer Research, International Journal of Pharmaceutics, Clinical Cancer Research, Blood and Journal of Pharmacokinetics and Pharmacodynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.